JPRN-C000000010已完成未知
Cyclosporine C0 monitoring for frequently relapsing nephrotic syndrome in children - Cyclosporine C0 monitoring for frequently relapsing nephrotic syndrome in children
Japanese Study Group of Renal Disease in Children0 个研究点目标入组 60 人开始时间: 2005年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Other renal or systemic forms of nephrotic syndrome defined on renal biopsy, clinical features or serology (Henoch-Schönlein nephritis, systemic lupus erythematosus). 2.History of steroid-resistance. 3.Medical history of allergy or hypersensitivity reactions to cyclosporine. 4.Poorly controlled hypertension. 5.Chronic renal dysfunction. 6.Active infectious disease. 7.Severe liver disfunction. 8.History of cyclosporine administration. 9.Pregnancy. 10.Judged inappropriate for this study by the physicians.
研究者
相似试验
已完成
不适用
Cyclosporine C2 monitaring for frequently relapsing nephrotic syndrome in children: A randomized controlled trialFrequently relapsing nephrotic syndrome in childrenJPRN-C000000008Japanese Study Group of Kidney Disease in Children100
已完成
不适用
Optimizing of Ciclosporin monitoring, towards improved ciclosporine therapy in children after stem cell transplantatioatients undergoing an allogeneic stem cell transplantation due to a malignant or non-malignant immuno-hematologic disease.immuun reaction of transplant against the patients cellsGraft-versus-host diseaseNL-OMON36960eids Universitair Medisch Centrum110
招募中
3 期
Cyclosporin for the Prevention and Treatment of COVID-19 DiseaseIRCT20150107020592N22Shahid Beheshti University of Medical Sciences60
已完成
不适用
TRough vs AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in allogeneic stem cell recipients (TRAM-study)NL-OMON39871Vrije Universiteit Medisch Centrum60
招募中
不适用
TRough vs AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in allogeneic stem cell recipientsallogeneic stem cell transplantationcyclosporineTDMAdverse drug reactionsNL-OMON27177VU University Medical Center60